The Italian Journal of Neurological Sciences

, Volume 11, Issue 1, pp 77–77 | Cite as

Side effects of low-dose cyclosporin A in the treatment of multiple sclerosis

  • Bramanti P. 
  • Leo M. Di 
  • Ricci R. M. 
  • Luca G. P. De 
  • Bella P. Di 
  • Rifici C. 
Letters

Keywords

Public Health Multiple Sclerosis Cyclosporin 

References

  1. [1]
    Bailey R.R. et al.:Renal transplant recipients immunosuppressed with Sandimmun (CYA): 3 side effects possibly attributable to CYA. N.Z. med. J., 98,915–916, 1985.PubMedGoogle Scholar
  2. [2]
    Ballantyne C.M. et al.Hyperlipidemia following heart transplantation Transplant. Rev. 65:5, 1982Google Scholar
  3. [3]
    Britton S., Palacios R.:Cyclosporin A: Usefulness, risks and mechanisms of action. Immunol. Rev. 65:5, 1982.PubMedGoogle Scholar
  4. [4]
    Kappos L., Patzold U.:Cyclosporine versus Azathioprine in the long-term treatment of Multiple Sclerosis. Results of the German Multicenter study Ann. Neurol. 23:56–63, 1988.CrossRefPubMedGoogle Scholar
  5. [5]
    Michel F., Baguet J.C., Grapin C.H. et al.:Bone marrow toxicity of Sandimmun (CYA)? A case report Lancet II, 394, 1986.Google Scholar

Copyright information

© Masson Italia Periodici S.r.l. 1990

Authors and Affiliations

  • Bramanti P. 
    • 1
  • Leo M. Di 
    • 1
  • Ricci R. M. 
    • 1
  • Luca G. P. De 
    • 1
  • Bella P. Di 
    • 1
  • Rifici C. 
    • 1
  1. 1.Cattedra di NeurofisiopatologiaUniversità di MessinaMessinaItaly

Personalised recommendations